Callodine Capital Management, LP Haemonetics Corp Transaction History

Callodine Capital Management, LP

  • $428 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$49.55 - $74.59 $2.48 Million - $3.73 Million
-50,000 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$57.6 - $70.59 $2.88 Million - $3.53 Million
-50,000 Reduced 50.0%
50,000 $3.53 Million
Q2 2021

Aug 13, 2021
BUY
$51.81 - $118.56 $5.18 Million - $11.9 Million
100,000 New
100,000 $6.66 Million

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Callodine Capital Management, LP Portfolio

Follow Callodine Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callodine Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Callodine Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email